To investigate the effect of 18:0 Lyso PC on non-alcoholic fatty liver disease, the concentrations of aspartate transaminase (AST) and alanine transaminase (ALT) in the serum were measured. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.